Hospital HM Nens
- Address
- Calle Consell De Cent 437, 08009 Barcelona, Spain
Nutritional and Metabolic Diseases
Hospital HM Nens is advancing research on lactose intolerance, seeking to confirm a urinary xylose cut‑off that can reliably identify hypolactasic children during routine clinical evaluation.
- Evaluation of LacTEST diagnostic accuracy
- Establishing urinary xylose thresholds for pediatric screening
This work aims to improve early detection and management of lactose malabsorption in young patients.
Musculoskeletal Diseases
The site is conducting a study on polyarticular‑course juvenile idiopathic arthritis, examining the safety, tolerability, and therapeutic benefit of the oral agent filgotinib in children and adolescents.
- Safety and tolerability assessment in pediatric JIA
- Pharmacokinetic profiling of filgotinib
- Efficacy outcomes for disease activity reduction
The investigation seeks to provide a new treatment option for a condition that significantly impacts young patients' mobility and quality of life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Alfasigma S.p.A.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital HM Nens
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Gaxilose Efficacy for Diagnosing Hypolactasia in Pediatric Patients with Lactose Intolerance Symptoms | Venter Pharma S.L. | Phase III | Recruiting | Jul 2025 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Filgotinib | 1 | Unknown | 2026-04-27 | 2026-04-27 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.